XRN-PB

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 34.62 M37.97 M37.23 M38.39 M38.06 M39.75 M 153.43 M Gross profit 34.62 M37.97 M37.23 M38.39 M38.06 M39.75 M 153.43 M Operating expenses 15.05 M18.56 M17.17 M18.84 M17.75 M25.29 M 79.06 M Selling/general/admin expenses 3.62 M6.03 M4.86 M5.49 M5.09 M5.22 M 20.66 M Research & development —————— — Operating income 27.03 M19.41 M20.05 M19.55 M28.81 M29.71 M 98.13 M Non-Operating Income, Total 1.36 M———-7.23 M63.08 M — Interest expense, net of interest capitalized 7.17 M8.01 M8.18 M8.4 M7.23 M8.81 M 32.62 M Non-Operating Income, excl. Interest Expenses 1.36 M———-14.47 M54.27 M — Unusual income/expense —————— — Pretax income 27.15 M27.63 M28.28 M28.14 M29.56 M31.02 M 117 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest 178 K-70 K-512 K-643 K-70 K6.01 M 4.78 M After tax other income/expense -25 K-45 K18 K-53 K53 K-185 K -167 K Net income before discontinued operations 3.74 M585 K-5.35 M-5.78 M1.65 M400 K -9.07 M Discontinued operations 1.36 M207 K294 K-372 K071.88 M 71.8 M Net income 3.74 M585 K-5.06 M-6.15 M1.65 M72.28 M 62.73 M Dilution adjustment -178 K70 K512 K643 K70 K-6.01 M -4.78 M Preferred dividends 1.46 M1.46 M1.46 M1.92 M2.47 M2.98 M 8.82 M Diluted net income available to common stockholders 2.1 M-800 K-6 M-7.42 M-749 K63.29 M 49.12 M Basic earnings per share (Basic EPS) 0.15-0.05-0.45-0.56-0.064.78 3.71 Diluted earnings per share (Diluted EPS) 0.17-0.05-0.45-0.56-0.064.78 3.71 Average basic shares outstanding 13.37 M13.38 M13.39 M13.38 M13.23 M13.23 M — Diluted shares outstanding 13.37 M13.38 M13.39 M13.38 M13.23 M13.23 M — EBITDA 33.39 M34.7 M35.06 M34.46 M35.14 M29.73 M 134.4 M EBIT 19.57 M19.41 M20.05 M19.55 M20.31 M14.46 M 74.37 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 13.83 M15.29 M15.01 M14.92 M14.83 M15.28 M 60.03 M